共 63 条
Hereditary haemorrhagic telangiectasia: a clinical and scientific review
被引:341
作者:
Govani, Fatima S.
[2
]
Shovlin, Claire L.
[1
,2
]
机构:
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Resp Med, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci, London, England
关键词:
nosebleeds;
anaemia;
AVMs;
stroke;
endothelial;
TGF-beta;
PULMONARY ARTERIOVENOUS-MALFORMATIONS;
ENDOTHELIAL-CELL PROLIFERATION;
WEBER-RENDU-SYNDROME;
CONTRAST ECHOCARDIOGRAPHY;
JUVENILE POLYPOSIS;
ARAB FAMILY;
ENDOGLIN;
ALK1;
MUTATIONS;
GENOTYPE;
D O I:
10.1038/ejhg.2009.35
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The autosomal-dominant trait hereditary haemorrhagic telangiectasia (HHT) affects 1 in 5-8000 people. Genes mutated in HHT (most commonly for endoglin or activin receptor-like kinase (ALK1)) encode proteins that modulate transforming growth factor (TGF)-beta superfamily signalling in vascular endothelial cells; mutations lead to the development of fragile telangiectatic vessels and arteriovenous malformations. In this article, we review the underlying molecular, cellular and circulatory pathobiology; explore HHT clinical and genetic diagnostic strategies; present detailed considerations regarding screening for asymptomatic visceral involvement; and provide overviews of management strategies.
引用
收藏
页码:860 / 871
页数:12
相关论文